These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17571562)

  • 21. Visceral fat as target of highly active antiretroviral therapy-associated metabolic syndrome.
    Barbaro G
    Curr Pharm Des; 2007; 13(21):2208-13. PubMed ID: 17627554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of adiponectin in adipocytes upon exposure to HIV-1.
    Sankalé JL; Tong Q; Hadigan CM; Tan G; Grinspoon SK; Kanki PJ; Hotamisligil GS
    HIV Med; 2006 May; 7(4):268-74. PubMed ID: 16630040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adipose tissue biology and HIV-infection.
    Giralt M; Domingo P; Villarroya F
    Best Pract Res Clin Endocrinol Metab; 2011 Jun; 25(3):487-99. PubMed ID: 21663842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIDS-related lipodystrophy/insulin resistance syndrome.
    Kino T; Mirani M; Alesci S; Chrousos GP
    Horm Metab Res; 2003 Mar; 35(3):129-36. PubMed ID: 12734771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 Tat protein impairs adipogenesis and induces the expression and secretion of proinflammatory cytokines in human SGBS adipocytes.
    Díaz-Delfín J; Domingo P; Wabitsch M; Giralt M; Villarroya F
    Antivir Ther; 2012; 17(3):529-40. PubMed ID: 22301094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lipodystrophies related to antiretroviral treatment of HIV infection].
    Capeau J; Caron M; Vigouroux C; Cervera P; Kim M; Maachi M; Lagathu C; Bastard JP
    Med Sci (Paris); 2006 May; 22(5):531-6. PubMed ID: 16687123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential gene expression indicates that 'buffalo hump' is a distinct adipose tissue disturbance in HIV-1-associated lipodystrophy.
    Guallar JP; Gallego-Escuredo JM; Domingo JC; Alegre M; Fontdevila J; Martínez E; Hammond EL; Domingo P; Giralt M; Villarroya F
    AIDS; 2008 Mar; 22(5):575-84. PubMed ID: 18316998
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered expression of nucleoside transporter genes (SLC28 and SLC29) in adipose tissue from HIV-1-infected patients.
    Guallar JP; Cano-Soldado P; Aymerich I; Domingo JC; Alegre M; Domingo P; Villarroya F; Javier Casado F; Giralt M; Pastor-Anglada M
    Antivir Ther; 2007; 12(6):853-63. PubMed ID: 17926640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Body fat changes among antiretroviral-naive patients on PI- and NNRTI-based HAART in the Swiss HIV cohort study.
    Young J; Rickenbach M; Weber R; Furrer H; Bernasconi E; Hirschel B; Tarr PE; Vernazza P; Battegay M; Bucher HC
    Antivir Ther; 2005; 10(1):73-81. PubMed ID: 15751765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Switching to nevirapine decreases insulin levels but does not improve subcutaneous adipocyte apoptosis in patients with highly active antiretroviral therapy-associated lipodystrophy.
    Domingo P; Matías-Guiu X; Pujol RM; Domingo JC; Arroyo JA; Sambeat MA; Vázquez G
    J Infect Dis; 2001 Nov; 184(9):1197-201. PubMed ID: 11598845
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depot-specific adipocyte cell lines reveal differential drug-induced responses of white adipocytes--relevance for partial lipodystrophy.
    Kovsan J; Osnis A; Maissel A; Mazor L; Tarnovscki T; Hollander L; Ovadia S; Meier B; Klein J; Bashan N; Rudich A
    Am J Physiol Endocrinol Metab; 2009 Feb; 296(2):E315-22. PubMed ID: 19033543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum leptin concentrations and fat redistribution in HIV-1-infected children on highly active antiretroviral therapy.
    Dzwonek AB; Novelli V; Schwenk A
    HIV Med; 2007 Oct; 8(7):433-8. PubMed ID: 17760735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Some HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophages.
    Lagathu C; Eustace B; Prot M; Frantz D; Gu Y; Bastard JP; Maachi M; Azoulay S; Briggs M; Caron M; Capeau J
    Antivir Ther; 2007; 12(4):489-500. PubMed ID: 17668557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
    He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
    Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of the HIV protease inhibitor ritonavir on proliferation, differentiation, lipogenesis, gene expression and apoptosis of human preadipocytes and adipocytes.
    Grigem S; Fischer-Posovszky P; Debatin KM; Loizon E; Vidal H; Wabitsch M
    Horm Metab Res; 2005 Oct; 37(10):602-9. PubMed ID: 16278782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Body-fat abnormalities in patients with HIV: progress and challenges.
    Bedimo RJ
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(6):292-305. PubMed ID: 19056708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
    Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
    Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of plasma PAI-1 concentrations in HAART-associated lipodystrophy during rosiglitazone therapy.
    Yki-Järvinen H; Sutinen J; Silveira A; Korsheninnikova E; Fisher RM; Kannisto K; Ehrenborg E; Eriksson P; Hamsten A
    Arterioscler Thromb Vasc Biol; 2003 Apr; 23(4):688-94. PubMed ID: 12615670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Lipodystrophy and lipid metabolism alterations in HIV-infected patients receiving highly active antiretroviral therapy (HAART)].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2004 May; 95(5):265-75. PubMed ID: 15202680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early changes in adipokine levels and baseline limb fat may predict HIV lipoatrophy over 2 years following initiation of antiretroviral therapy.
    Calmy A; Carey D; Mallon PW; Wand H; Law M; Cooper DA; Carr A; ;
    HIV Med; 2008 Feb; 9(2):101-10. PubMed ID: 18257772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.